|
|
Volumn 44, Issue 2, 2013, Pages 109-
|
|
Recalcitrant neovascular macular degeneration after anti-VEGF therapy: An ongoing challenge
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
RANIBIZUMAB;
VASCULOTROPIN;
ANGIOGENESIS INHIBITOR;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
VEGFA PROTEIN, HUMAN;
BINDING AFFINITY;
DRUG MEGADOSE;
EXUDATIVE MACULAR DEGENERATION;
OPTICAL COHERENCE TOMOGRAPHY;
PRIORITY JOURNAL;
RETINA DETACHMENT;
RETINA MACULA EDEMA;
REVIEW;
SUBRETINAL FLUID;
TREATMENT DURATION;
VISION;
VISUAL ACUITY;
VISUAL IMPAIRMENT;
DRUG ANTAGONISM;
FEMALE;
HUMAN;
MALE;
NOTE;
DOSAGE SCHEDULE COMPARISON;
FOLLOW UP;
RETINA MACULA AGE RELATED DEGENERATION;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
FEMALE;
HUMANS;
MALE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
WET MACULAR DEGENERATION;
|
|
EID: 84876001208
PISSN: 23258160
EISSN: 23258179
Source Type: Journal
DOI: 10.3928/23258160-20130313-01 Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|
